Junya Ohtake

699 total citations
18 papers, 524 citations indexed

About

Junya Ohtake is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Junya Ohtake has authored 18 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 13 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Junya Ohtake's work include Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune Cell Function and Interaction (6 papers). Junya Ohtake is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Immune Cell Function and Interaction (6 papers). Junya Ohtake collaborates with scholars based in Japan and United States. Junya Ohtake's co-authors include Hidemitsu Kitamura, Norihiko Takahashi, Shigenori Homma, Yosuke Ohno, Akinobu Taketomi, Hideki Kawamura, Yujiro Toyoshima, Koichi Azuma, Yuki Fujimoto and Takashi Nishimura and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Junya Ohtake

18 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junya Ohtake Japan 10 296 276 192 68 54 18 524
Janina Dörr Germany 2 253 0.9× 263 1.0× 177 0.9× 59 0.9× 49 0.9× 2 530
Dmitrij Ostroumov Germany 5 337 1.1× 294 1.1× 137 0.7× 63 0.9× 60 1.1× 6 526
Paula Dobosz Poland 8 264 0.9× 196 0.7× 164 0.9× 47 0.7× 46 0.9× 28 504
Ashwat Nagarajan United States 3 335 1.1× 313 1.1× 178 0.9× 59 0.9× 68 1.3× 4 620
Jeanne Galaine France 12 298 1.0× 303 1.1× 158 0.8× 58 0.9× 51 0.9× 28 512
Naoshi Kawamura Japan 10 233 0.8× 204 0.7× 156 0.8× 57 0.8× 46 0.9× 12 456
Qiu‐Xia Qu China 13 474 1.6× 466 1.7× 142 0.7× 73 1.1× 104 1.9× 33 734
Gabriela Turcu Romania 10 288 1.0× 174 0.6× 117 0.6× 57 0.8× 74 1.4× 26 463
Daniele Generali Italy 10 232 0.8× 121 0.4× 156 0.8× 84 1.2× 114 2.1× 26 475

Countries citing papers authored by Junya Ohtake

Since Specialization
Citations

This map shows the geographic impact of Junya Ohtake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junya Ohtake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junya Ohtake more than expected).

Fields of papers citing papers by Junya Ohtake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junya Ohtake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junya Ohtake. The network helps show where Junya Ohtake may publish in the future.

Co-authorship network of co-authors of Junya Ohtake

This figure shows the co-authorship network connecting the top 25 collaborators of Junya Ohtake. A scholar is included among the top collaborators of Junya Ohtake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junya Ohtake. Junya Ohtake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Iiizumi, Susumu, Junya Ohtake, Taku Kouro, et al.. (2019). Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers. 11(2). 266–266. 23 indexed citations
3.
Matsuo, Norikazu, Koichi Azuma, Satoshi Hattori, et al.. (2018). Association between soluble immune mediators and tumor responses in patients with nonsmall cell lung cancer treated with anti‐PD‐1 inhibitor. International Journal of Cancer. 144(5). 1170–1179. 29 indexed citations
4.
Kitamura, Hidemitsu, Yosuke Ohno, Yujiro Toyoshima, et al.. (2017). Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Science. 108(10). 1947–1952. 199 indexed citations
5.
Wada, Satoshi, Erica Yada, Junya Ohtake, & Tetsuro Sasada. (2017). Personalized peptide vaccines for cancer therapy: current progress and state of the art. Expert Review of Precision Medicine and Drug Development. 2(6). 371–381. 8 indexed citations
6.
Ohno, Yosuke, Hidemitsu Kitamura, Norihiko Takahashi, et al.. (2016). IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells. Cancer Immunology Immunotherapy. 65(2). 193–204. 89 indexed citations
7.
Wada, Satoshi, et al.. (2016). Current Status and Future Prospects of Peptide-Based Cancer vaccines. Immunotherapy. 8(11). 1321–1333. 10 indexed citations
8.
Sasada, Tetsuro, Koichi Azuma, Junya Ohtake, & Yuki Fujimoto. (2016). Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment. Frontiers in Pharmacology. 7. 405–405. 42 indexed citations
9.
Ohtake, Junya, Satoshi Wada, Yuki Fujimoto, et al.. (2016). Personalized immunotherapy in colorectal cancer. Expert Review of Precision Medicine and Drug Development. 1(3). 267–277. 2 indexed citations
10.
Sumida, Kentaro, Yosuke Ohno, Junya Ohtake, et al.. (2015). IL-11 induces differentiation of myeloid-derived suppressor cells through activation of STAT3 signalling pathway. Scientific Reports. 5(1). 13650–13650. 23 indexed citations
11.
Ohno, Yosuke, Hidemitsu Kitamura, Junya Ohtake, et al.. (2015). IL-6/STAT3 signaling impaired induction of cancer-antigen specific T cells via down-regulation of dendritic cells in tumor microenvironment.. Journal of Clinical Oncology. 33(3_suppl). 590–590. 1 indexed citations
12.
Ohtake, Junya, Takayuki Ohkuri, Daisuke Noguchi, et al.. (2014). Identification of a meiosis-specific protein, MEIOB, as a novel cancer/testis antigen and its augmented expression in demethylated cancer cells. Immunology Letters. 158(1-2). 175–182. 9 indexed citations
13.
Ohtake, Junya, Takayuki Ohkuri, Yuji Togashi, et al.. (2014). Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine. Immunology Letters. 161(1). 20–30. 24 indexed citations
14.
Sumida, Kentaro, et al.. (2014). Abstract 3661: Crucial roles of cytokine-signaling for alteration in functions of myeloid-derived suppressor cells. Cancer Research. 74(19_Supplement). 3661–3661. 2 indexed citations
15.
Kitamura, Hidemitsu, Junya Ohtake, Satoshi Terada, et al.. (2014). Activation of IL-6/STAT3-signaling cascade induces suppression of antigen presentation by human dendritic cells (TUM4P.917). The Journal of Immunology. 192(Supplement_1). 138.18–138.18. 1 indexed citations
16.
Terada, Satoshi, et al.. (2014). IL-17 regulates Toll-like receptor-mediated activation of dendritic cells (TUM4P.905). The Journal of Immunology. 192(Supplement_1). 138.6–138.6. 1 indexed citations
17.
Watanabe, Kazue, Shingo Toji, Junya Ohtake, et al.. (2013). Establishment of a stable T lymphoma cell line transduced with HLA-A^|^lowast;24:02-restricted WT1-specific TCR genes and its application to antigen-specific immunomonitoring. Biomedical Research. 34(1). 41–50. 4 indexed citations
18.
Takahashi, Norihiko, Takayuki Ohkuri, Shigenori Homma, et al.. (2012). First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen. Cancer Science. 103(1). 150–153. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janina Dörr Breakdown of academic impact, for papers by Dmitrij Ostroumov Breakdown of academic impact, for papers by Paula Dobosz Breakdown of academic impact, for papers by Ashwat Nagarajan Breakdown of academic impact, for papers by Jeanne Galaine Breakdown of academic impact, for papers by Naoshi Kawamura Breakdown of academic impact, for papers by Qiu‐Xia Qu Breakdown of academic impact, for papers by Gabriela Turcu Breakdown of academic impact, for papers by Daniele Generali
Rankless by CCL
2026